ProFuse Technology Raises $3 Million in Seed Funding to Revolutionize Muscle Cultivation in Cultivated Meat and Life Science Industries

ProFuse Technology, a pioneering company dedicated to advancing muscle cultivation technologies for the cultivated meat and life science industries, has announced the successful raising of $2.4 million in its latest funding round. This latest investment comes on the heels of earlier funding successes, including $3 million raised in a previous round led by Green-Circle. Established in 2021, ProFuse Technology has built its foundation on six years of rigorous research conducted at the esteemed Weizmann Institute of Science, focusing on innovative solutions such as cell lines, media supplements, and cultivation methods. Central to ProFuse's offering is its flagship product, PROFUSE-S1, a differentiation media supplement that markedly accelerates the differentiation, fusion, and maturation of muscle progenitor cells. By incorporating PROFUSE-S1, cultivated meat companies can enhance production efficiency, achieving faster generation times for muscle tissues while maintaining consistency and reliability in results. Furthermore, life science sectors employing ProFuse's technologies can develop effective in vitro muscle models, instrumental in drug discovery and tissue engineering applications. The new funding will be strategically utilized to expand product development and scale operations, cementing ProFuse's position as a leader in the rapidly growing foodtech landscape. This recent infusion of capital reaffirms investor confidence in ProFuse’s vision to revolutionize muscle cultivation and supports its commitment to providing the cultivated meat industry with essential tools for sustainable production. As ProFuse Technology continues to drive innovation, it remains dedicated to not only meeting the needs of the industry but also making a substantial impact on the future of food and life sciences.